Transfusion Medicine
Deep Expertise in Immune-mediated Blood Cell Destruction
For more than 50 years, physicians and lab professionals of Versiti Diagnostics have specialized in resolution of serological transfusion problems and evaluation of autoimmune, DAT-negative and drug-induced hemolytic anemia. Our team is experienced in solving the most difficult transfusion medicine challenges and has designed our red cell genotyping services to help meet those needs—ensuring timely solutions for patients in need.
Approach
Versiti Diagnostics’ Immunohematology Reference Laboratories have earned a reputation for solving complex serological transfusion problems. We specialize in evaluation of autoimmune, DAT-negative, drug-induced hemolytic anemia and the provision of specialty matched red cell products. Each year, we receive samples from across the country for detection of drug-dependent red cell antibodies and Super Coombs testing.
Our laboratories are supported in these activities by their stock of rare reagents, skill, special techniques, and high level of training and expertise. As an active participant in the American Rare Donor Program (ARDP), we maintain a large inventory of rare blood at our four locations.
Kathleen Puca, MD, MT (ASCP) SBB
Dr. Puca is a senior medical director of transfusion medicine who provides transfusion and coagulation support for cardiac surgery patients.
Angela Treml, MD
Dr. Treml is a medical director of transfusion medicine.
Transfusion Medicine Research
Transfusion medicine has a long history at Versiti, reflecting our longstanding mission to provide a safe supply of blood products to our communities. Early on, discoveries made at Versiti Blood Research Institute were critical in improving patient outcomes related to transfusion. Currently, investigators study the basic biology and clinical implications of a wide range of transfusion-related issues.